NCT02302612

Brief Summary

Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive, and high-risk segment of the U.S. population. The investigators are testing a multi-component behavioral intervention designed to help complex patients with CVD and other concurrent chronic conditions to become more effective agents of their own care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
647

participants targeted

Target at P75+ for not_applicable diabetes

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 27, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
Last Updated

October 16, 2018

Status Verified

October 1, 2018

Enrollment Period

3.7 years

First QC Date

November 21, 2014

Last Update Submit

October 15, 2018

Conditions

Keywords

chronic conditionscomplex patientsengagementactivation

Outcome Measures

Primary Outcomes (1)

  • Composite CVD Goal

    We will compare the proportion of patients in the two study arms who achieve all three clinical goals of the PHASE disease management program (blood pressure control, HbA1c control (if applicable), and statin prescription) 12 months after enrollment. Risk factor control is defined according to the PHASE disease management program protocol.

    12-months

Secondary Outcomes (3)

  • Perceived efficacy in patient-physician interactions (PEPPI) - 10 items

    6 months

  • Effective Consumer Scale (EC-17)

    6 months

  • Patient Activation Measure (PAM) - 13 items

    6 months

Study Arms (2)

CREATE Wellness

EXPERIMENTAL

Patients allocated to the intervention arm will receive three group sessions with between visit contacts designed to increase activation and engagement with their care plans. They will also continue to be enrolled in the KP PHASE disease management program.

Behavioral: CREATE Wellness

Usual Care Control

ACTIVE COMPARATOR

Patients allocated to the control arm will continue to receive usual care, including disease management within the KP PHASE program.

Other: Usual Care Control

Interventions

CREATE WellnessBEHAVIORAL

Patients allocated to the intervention arm will receive three group sessions with between visit contacts designed to increase activation and engagement with their care plans. They will also continue to be enrolled in the KP PHASE program

CREATE Wellness

Patients allocated to the control arm will continue to receive usual care, including disease management within the KP PHASE program.

Usual Care Control

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Kaiser Permanente Northern California members enrolled in the PHASE disease management program and not meeting all goals of care for the preceding 2 years.

You may not qualify if:

  • Schizophrenia or personality disorder
  • Unable to communicate in English
  • Unwilling to participate in group-based in-person program
  • Pregnant
  • Terminal or debilitating illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaiser Permanente San Jose Sabrina Wood, BA (510) 891-3551 Sabrina.B.Wood@kp.org

San Jose, California, 95119, United States

Location

Related Publications (3)

  • Iturralde E, Sterling SA, Uratsu CS, Mishra P, Ross TB, Grant RW. Changing Results-Engage and Activate to Enhance Wellness: A Randomized Clinical Trial to Improve Cardiovascular Risk Management. J Am Heart Assoc. 2019 Dec 3;8(23):e014021. doi: 10.1161/JAHA.119.014021. Epub 2019 Nov 30.

  • Torres DX, Lu WY, Uratsu CS, Sterling SA, Grant RW. Knowing How to Ask Good Questions: Comparing Latinos and Non-Latino Whites Enrolled in a Cardiovascular Disease Prevention Study. Perm J. 2019;23:18-258. doi: 10.7812/TPP/18-258.

  • Miller-Rosales C, Sterling SA, Wood SB, Ross T, Makki M, Zamudio C, Kane IM, Richardson MC, Samayoa C, Charvat-Aguilar N, Lu WY, Vo M, Whelan K, Uratsu CS, Grant RW. CREATE Wellness: A multi-component behavioral intervention for patients not responding to traditional Cardiovascular disease management. Contemp Clin Trials Commun. 2017 Oct 4;8:140-146. doi: 10.1016/j.conctc.2017.10.001. eCollection 2017 Dec.

MeSH Terms

Conditions

Diabetes MellitusHeart DiseasesHypertensionDyslipidemiasChronic Disease

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCardiovascular DiseasesVascular DiseasesLipid Metabolism DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Richard W Grant, MD MPH

    Division of Research, KPNC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2014

First Posted

November 27, 2014

Study Start

January 1, 2015

Primary Completion

September 30, 2018

Study Completion

September 30, 2018

Last Updated

October 16, 2018

Record last verified: 2018-10

Locations